Insulin aspart, recombinant Subcutaneous and Nelarabine Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Nelarabine Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: nelarabine
Brand name: Arranon
Synonyms: Nelarabine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Nelfinavir
- Insulin aspart, recombinant Subcutaneous-Nelfinavir Mesylate
- Insulin aspart, recombinant Subcutaneous-Nelfinavir Oral Powder
- Insulin aspart, recombinant Subcutaneous-Nelfinavir Tablets
- Insulin aspart, recombinant Subcutaneous-Nembutal
- Insulin aspart, recombinant Subcutaneous-Nembutal Sodium injection
- Nelarabine Intravenous-Insulin degludec
- Nelarabine Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Nelarabine Intravenous-Insulin Degludec (U-100) Vials
- Nelarabine Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Nelarabine Intravenous-Insulin degludec and liraglutide
- Nelarabine Intravenous-Insulin degludec and liraglutide Subcutaneous